NCT00810212View on ClinicalTrials.gov

Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar Fusion

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2008

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Degenerative Disc DiseaseDegenerative SpondylolisthesisSpinal Stenosis
Interventions
PROCEDURE

PLF with autograft

6 subjects

BIOLOGICAL

PLF with NeoFuse

6 subjects low dose

BIOLOGICAL

PLF with NeoFuse

6 subjects medium dose

BIOLOGICAL

PLF with NeoFuse

6 subjects high dose

Trial Locations (1)

75093

Texas Back Institute, Plano

Sponsors

Lead Sponsor

Mesoblast, Ltd.
All Listed Sponsors
lead

Mesoblast, Ltd.

INDUSTRY

NCT00810212 - Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar Fusion | Biotech Hunter | Biotech Hunter